Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report

BACKGROUND: Buprenorphine is a partial mu-opioid receptor agonist approved for the treatment of opioid dependence. The risk of withdrawal symptoms and wait time required to safely initiate buprenorphine provides challenges to both patients and providers. Microdose induction is proposed as a possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Menard, Shannon, Jhawar, Archana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582770/
https://www.ncbi.nlm.nih.gov/pubmed/34824962
http://dx.doi.org/10.9740/mhc.2021.11.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582770/
https://www.ncbi.nlm.nih.gov/pubmed/34824962
http://dx.doi.org/10.9740/mhc.2021.11.369

Ejemplares similares